Graftac 5 Prolonged Release
Capsules
registration number
55/34/0856
What Graftac 5 Prolonged Release contains
Each capsule contains 5,000 mg of tacrolimus equivalent to 5,112 mg of tacrolimus monohydrate.
other ingredients
Capsule content: Ethylcellulose, hypromellose type 2910, lactose monohydrate, magnesium stearate
Body Composition: Sunset yellow FCF (E110), allura red AC (E129), brilliant blue FCF (E133), titanium dioxide (E171), gelatine
Cap Composition: Erythrosin (E127), titanium dioxide (E171), Gelatine
Imprinting ink: Shellac Glaze in ethanol, N-butyl alcohol, allura Red AC aluminium lake (E129), brilliant blue FCF aluminium lake (E133), isopropyl alcohol, sunset yellow FCF aluminium lake (E110), propylene glycol (E1520), lecithin (soya), simeticone.
Therapeutic classification
A.34 Other (Immuno-suppressive macrolide lactone).